Eirini Papapetrou
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
iPSCsGoogle:
"Eirini Papapetrou"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Papapetrou EP. (2023) Base editors dissect genetic variants in human hematopoietic cells on a large scale. Trends in Immunology. 44: 490-492 |
| Kotini AG, Carcamo S, Cruz-Rodriguez N, et al. (2023) Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia. Blood Cancer Discovery. OF1-OF18 |
| Papapetrou EP. (2022) MDS/AML with del5q: An acquired "laminopathy"? Cell Stem Cell. 29: 498-499 |
| Asimomitis G, Deslauriers AG, Kotini AG, et al. (2022) Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs. Blood Advances |
| Alves da Silva PH, Xing S, Kotini AG, et al. (2021) MICA/B antibody induces macrophage-mediated immunity against acute myeloid leukemia. Blood |
| Wang T, Pine AR, Kotini AG, et al. (2021) Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets. Cell Stem Cell |
| Doulatov S, Papapetrou EP. (2021) Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells. Current Opinion in Hematology. 28: 50-56 |
| Deslauriers AG, Kotini AG, Papapetrou EP. (2021) Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 2185: 411-422 |
| Spyrou N, Papapetrou EP. (2020) Studying leukemia stem cell properties and vulnerabilities with human iPSCs. Stem Cell Research. 50: 102117 |
| Doulatov S, Papapetrou EP. (2020) Studying clonal evolution of myeloid malignancies using induced pluripotent stem cells. Current Opinion in Hematology |